BlackRock Investment Management, LLC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 171 filers reported holding ARRAY BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q4 2016$5,937,000
+47.7%
675,469
+13.4%
0.01%
+40.0%
Q3 2016$4,019,000
+90.7%
595,435
+0.6%
0.01%
+66.7%
Q2 2016$2,107,000
+46.5%
591,989
+21.4%
0.00%
+50.0%
Q1 2016$1,438,000
-29.0%
487,467
+1.6%
0.00%
-33.3%
Q4 2015$2,024,000
-7.5%
479,611
-0.0%
0.00%0.0%
Q3 2015$2,187,000
-37.7%
479,668
-1.5%
0.00%
-25.0%
Q2 2015$3,512,000
+13.9%
487,155
+16.5%
0.00%0.0%
Q1 2015$3,083,000
+75.3%
418,251
+12.5%
0.00%
+100.0%
Q4 2014$1,759,000
+30.0%
371,942
-1.9%
0.00%0.0%
Q3 2014$1,353,000
-21.2%
379,016
+0.7%
0.00%0.0%
Q2 2014$1,717,000
+6.5%
376,494
+9.7%
0.00%0.0%
Q1 2014$1,612,000
-4.7%
343,080
+1.6%
0.00%
-33.3%
Q4 2013$1,692,000
-17.8%
337,804
+2.1%
0.00%0.0%
Q3 2013$2,059,000
+45.9%
331,004
+6.5%
0.00%0.0%
Q2 2013$1,411,000310,6910.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q4 2016
NameSharesValueWeighting ↓
Redmile Group, LLC 15,978,580$268,121,0009.11%
BVF INC/IL 4,672,195$78,399,0007.65%
First Light Asset Management, LLC 2,391,575$40,131,0006.25%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 694,500$11,647,0004.47%
Copernicus Capital Management, LLC 286,797$4,812,0003.49%
PACIFIC VIEW ASSET MANAGEMENT, LLC 225,511$3,784,0003.00%
SECTORAL ASSET MANAGEMENT INC 1,566,477$26,285,0002.94%
X-Square Capital, LLC 173,802$2,917,0002.18%
DRIEHAUS CAPITAL MANAGEMENT LLC 2,618,654$43,941,0001.48%
Birchview Capital, LP 128,000$2,148,0001.46%
View complete list of ARRAY BIOPHARMA INC shareholders